U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT06872619) titled 'RegisterPROS - a Registry for Prostate Cancers' on March 06.
Brief Summary: Prostate cancers are derived from epithelial cells in the prostate gland. Treatment options include surgery, medical (androgen signaling targeted and chemotherapy) and radiation therapy including radioligand therapy (RLT). Survival is linked to early and accurate diagnoses or to the effective detection of disease recurrence and/or treatment failure. One challenge is to develop accurate non-invasive tests that can detect prostate cancer disease activity. A second challenge is to evaluate the effectiveness of such biomarkers during the natural history of this...